2607004723
  • Open Access
  • Review

Phytochemical Profile of Prosopis farcta (Banks & Sol.) J.F. Macbr.: A Comprehensive Review

  • Nabeel Shihab Ahmed Jolaq 1,*,   
  • İpek Süntar 2

Received: 24 Jun 2026 | Revised: 19 Jul 2026 | Accepted: 27 Jul 2026 | Published: 13 Aug 2026

Abstract

Prosopis farcta (Banks & Sol.) J.F. Macbr., a member of the Fabaceae family, is a medicinal plant widely distributed in arid and semi-arid regions and traditionally used for the treatment of diabetes, infections, inflammatory disorders, and metabolic diseases. Owing to its rich phytochemical composition, the species has attracted increasing scientific attention. This review comprehensively summarizes phytochemical studies conducted on P. farcta, with particular emphasis on the distribution of secondary metabolites in different plant organs and the analytical approaches employed for their characterization. The available evidence demonstrates that P. farcta possesses a diverse phytochemical profile comprising alkaloids, fatty acids, flavonoids, phenolic acids, saponins, sterols, tannins, triterpenoids, and volatile constituents. Major bioactive compounds, including β-sitosterol, chlorogenic acid, gallic acid, kaempferol, lupeol, luteolin, and quercetin are considered to contribute significantly to the biological properties of the species. Comparative evaluation of the reviewed studies indicates that the phytochemical composition varies among plant organs and is influenced by geographical origin and environmental conditions. The findings further reveal that P. farcta exhibits remarkable anticancer, antidiabetic, anti-inflammatory, antimicrobial, antioxidant, and hypolipidemic activities. Moreover, its extracts have shown promising potential as reducing and stabilizing agents in the green synthesis of nanoparticles. Overall, the available literature identifies P. farcta as a valuable natural source of bioactive compounds with considerable pharmaceutical, nutraceutical, and biotechnological potential. Nevertheless, further metabolomic, genomic, and clinical studies are needed to validate its therapeutic applications and facilitate its future utilization.

References 

  • 1.

    Azani, N.; Babineau, M.; Bailey, C.D.; et al. A new subfamily classification of the Leguminosae based on a taxonomically comprehensive phylogeny: The Legume Phylogeny Working Group (LPWG). Taxon 2017, 66, 44–77.

  • 2.

    Henciya, S.; Seturaman, P.; James, A.R.; et al. Biopharmaceutical potentials of Prosopis spp. (Mimosaceae, Leguminosa). J. Food Drug Anal. 2017, 25, 187–196.

  • 3.

    Jolaq, N.S.A.; Pehlivan, S.; Süntar, İ. A Review Study on Traditional Therapeutic Uses of Prosopis L. Species. Mersin Lokman Hekim Derg. 2026, 16, 46–53. https://doi.org/10.31020/mutftd.1763945. (In Turkish).

  • 4.

    Sharifi-Rad, J.; El Menyiy, N.; Ydyrys, A.; et al. Bioactive compounds from Prosopis species as potential oxidative stress and inflammation modulators: An update on mechanisms. Minerva Biotechnol. Biomol. Res. 2023, 35, 127.

  • 5.

    Burkart, A.E. A monograph of the genus Prosopis (Leguminosae Subfam. Mimosoideae). J. Arnold Arbor. 1976, 57, 450–525. https://doi.org/10.5962/p.324722.

  • 6.

    Bohórquez-Medina, S.L.; Bohórquez-Medina, A.L.; de Lukacs Pereny, S.G.; et al. Traditional culinary uses, food applications, and potential health benefits of Peruvian Mesquite (Prosopis juliflora, Prosopis pallida), research advances and challenges: A review. J. Ethn. Foods 2025, 12, 10.

  • 7.

    Ahmed, E.F.; Sleem, A.A.; Abbas, F.A.; et al. Phytochemical constituents, HPLC-PDA-ESI-MS/MS profile and bioactivities of roots and rhizomes of Prosopis farcta. Nat. Prod. J. 2020, 10, 411–428.

  • 8.

    Gholamalipour Alamdari, E.; Taleghani, A. New bioactive compounds characterized by LC–MS and GC–MS in Prosopis farcta. J. Mass Spectrom. 2022, 57, e4884.

  • 9.

    Alrawi, M.S.; Aldubaisi, I.A.; Almehemdi, A.F. Chemotaxonomy of twelve Mimosoideae species in Iraq. IOP Conf. Ser. Earth Environ. Sci. 2023, 1252, 012085.

  • 10.

    Sharifi-Rad, J.; Zhong, J.; Ayatollahi, S.A.; et al. LC-ESI-QTOF-MS/MS characterization of phenolic compounds from Prosopis farcta (Banks & Sol.) J.F.Macbr. and their potential antioxidant activities. Cell. Mol. Biol. 2021, 67, 189–200.

  • 11.

    Rabeea, M.A.; Naeem, G.A.; Owaid, M.N.; et al. Phytosynthesis of Prosopis farcta fruit-gold nanoparticles using infrared and thermal devices and their catalytic efficacy. Inorg. Chem. Commun. 2021, 133, 108931.

  • 12.

    Albandar, I.; Radhi, O.A.; Al-Saadi, S.A.; et al. Eco-Friendly Synthesis of Silver Nanoparticles Using Prosopis farcta Fruit Extract and Evaluate Their Biological Applications. Pak. J. Life Soc. Sci. 2024, 22, 3653–3665.

  • 13.

    Namaei, M.H.; Solgi, R.; Tavakoli Kareshk, A. Prosopis farcta Extract Potentiates the Scolicidal Activity against Protoscolices of Hydatid Cysts. Proc. Natl. Acad. Sci. India Sect. B Biol. Sci. 2022, 92, 57–62.

  • 14.

    Jahromi, M.A.F.; Etemadfard, H.; Zebarjad, Z. Antimicrobial and antioxidant characteristics of volatile components and ethanolic fruit extract of Prosopis farcta (Bank & Soland.). Trends Pharm. Sci. Technol. 2018, 4, 177–186.

  • 15.

    Harzallah-Skhiri, F.; Jannet, H.B.; Hammami, S.; et al. Variation of volatile compounds in two Prosopis farcta (Banks et Sol.) Eig. (Fabales, Fabaceae = Leguminosae) populations. Flavour Fragrance J. 2006, 21, 484–487.

  • 16.

    Yousefi, T.; Nomiri, S.; Taebi, R.; et al. A Comprehensive Review of the Pharmacological Properties and Therapeutic Potential of Prosopis farcta. Acta Biochim. Iran. 2025, 4, 197–205.

  • 17.

    Shirzadi, H.; Shariatmadari, F.; Karimi Torshizi, M.A.; et al. Plant extract supplementation as a strategy for substituting dietary antibiotics in broiler chickens exposed to low ambient temperature. Arch. Anim. Nutr. 2020, 74, 206–221.

  • 18.

    Karimi, E.; Aidy, A.; Abbasi, N. Quantitative HPLC Analysis of Phenolic Compounds in Prosopis farcta from Two Different Ecological Zones of Iran. Chem. Technol. Ind. J. 2017, 12, 116-124.

  • 19.

    Kobarfard, F.; Ayatollahi, S.A.; Khosravi-Dehaghi, N.; et al. High-performance thin-layer chromatography fingerprinting, total phenolic and total flavonoid contents and anti-platelet-aggregation activities of Prosopis farcta extracts. Cell. Mol. Biol. 2020, 66, 8–14.

  • 20.

    Al-Waheeb, A.N. Chemical composition of Prosopis farcta (Banks & Soland) Macbride (Leguminoseae or Fabaceae) fruits. Iran. J. Ichthyol. 2021, 8, 120–126.

  • 21.

    Taha, I.G.; Abd almunim Baker, L.; Ibraheem, K. Current Insights into the biochemical and antimicrobial properties of Prosopis farcta plant extract in rats with induced diarrhea. Iraqi J. Sci. 2026, 67, 1302–1312.

  • 22.

    Akrawi, S.H.; Attimarad, M.; Al-Dhubaib, B.; et al. Isolation and identification of the chemical ingredients of Prosopis farcta leaf extract using 13C and ¹H-NMR spectroscopy. Trop. J. Pharm. Res. 2021, 20, 2559–2565.

  • 23.

    Hasan Mohammed, I.; Zarial, V.; Moridi Farimani, M.; et al. In vitro assessment of the antihyperglycemic property of Prosopis farcta J.F. Macbr and Rheum ribes L. and phytochemical profiling of the most active extract. Trends Phytochem. Res. 2025, 9, 138–143. https://doi.org/10.57647/tpr.2025.0902.11.

  • 24.

    Abdulwahid-Kurdi, S.J. Detect Polyphenol and Fatty Acid Content of Two Wild Plants Collected in Mazne Sub-district, Kurdistan Region of Iraq. Curr. Res. Nutr. Food Sci. 2023, 11, 360–375.

  • 25.

    Abd-ElGawad, A.M.; Assaeed, A.M.; El Gendy, A.E.-N.; et al. Phytotoxicity of Rich Oxygenated Terpenes Essential Oil of Prosopis farcta against the Weed Dactyloctenium aegyptium. Separations 2023, 10, 361.

  • 26.

    Shahin, S.M.; Jaleel, A.; Alyafei, M.A.M. The Essential Oil-Bearing Plants in the United Arab Emirates (UAE): An Overview. Molecules 2021, 26, 6486.

  • 27.

    Saad, A.M.; Ghareeb, M.A.; Abdel-Aziz, M.S.; et al. Chemical constituents and biological activities of different solvent extracts of Prosopis farcta growing in Egypt. J. Pharmacogn. Phytother. 2017, 9, 67–76.

  • 28.

    Zhong, J.; Lu, P.; Wu, H.; et al. Current insights into phytochemistry, nutritional, and pharmacological properties of Prosopis plants. Evid.-Based Complement. Altern. Med. 2022, 2022, 2218029.

  • 29.

    Harzallah-Skhiri, F.; BenJannet, H. Favonoids Diversification in Organs of Two Prosopis Farcta (Banks & Sol.) Eig. (Leguminosea, Mimosoideae) Populations Occurring in the Northeast and the Southeast of Tunisia. J. Appl. Sci. Res. 2005, 1, 130–136.

  • 30.

    Dargah, M.M.; Pedram, P.; Cabrera-Barjas, G.; et al. Biomimetic synthesis of nanoparticles: A comprehensive review on green synthesis of nanoparticles with a focus on Prosopis farcta plant extracts and biomedical applications. Adv. Colloid Interface Sci. 2024, 332, 103277.

  • 31.

    Dheeb, B.I.; Hashim, S.S.; Hameed, R.K.; et al. Phytochemistry and biological activity of Prosopis farcta. J. Biotechnol. Res. Center 2020, 14, 25–33.

  • 32.

    Sevindik, E.; Sevindik, M.; Uysal, I.; et al. Biological and Nutritional Values of Prosopis farcta Fruit: A Phytochemical and Pharmacological Evaluation. Biol. Bull. 2025, 52, 287–297.

Share this article:
How to Cite
Jolaq, N. S. A.; Süntar, İ. Phytochemical Profile of Prosopis farcta (Banks & Sol.) J.F. Macbr.: A Comprehensive Review. Natural Products Analysis 2026, 2 (2), 100017. https://doi.org/10.53941/npa.2026.100017.
RIS
BibTex
Copyright & License
article copyright Image
Copyright (c) 2026 by the authors.